Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Addition Sequence of Ingredients – V 2.0

Posted on By

Elixir Department: SOP for Addition Sequence of Ingredients – V 2.0

Standard Operating Procedure for Addition Sequence of Ingredients in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/053/2025
Supersedes SOP/ELX/053/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for the correct sequence of addition of ingredients during elixir manufacturing to ensure proper mixing, product stability, and compliance with batch manufacturing instructions.

2. Scope

This SOP applies to all personnel involved in the addition of ingredients during the manufacturing of elixirs in the Elixir Department, including APIs, excipients, solvents, and additives.

3. Responsibilities

  • Manufacturing Operator:
    • Add ingredients as per the defined sequence in the BMR.
    • Ensure proper mixing after each addition.
  • Production Supervisor:
    • Verify each addition and sign the BMR.
  • QA Officer:
    • Perform in-process checks and ensure the sequence is followed as per procedure.
See also  Elixir Department: SOP for Sampling of Raw Materials for Elixirs - V 2.0

4. Accountability

The Production Head is accountable for ensuring all ingredients are added in the correct order and documented appropriately.

5. Procedure

5.1 General Guidelines

  1. Refer to the BMR for the prescribed sequence of addition for each batch.
  2. Ensure the manufacturing tank is prepared and clean as per SOP/ELX/051/2025.
  3. Use only verified and approved materials, with container and label checked prior to addition.

5.2 Typical Order of Addition

  1. Vehicle/Base Solvent: Add the main diluent (e.g., purified water, propylene glycol).
  2. Preservatives: Add dissolved preservatives such as sodium benzoate or methylparaben under stirring.
  3. Sweeteners: Add bulk sweeteners (sucrose/sorbitol) or intense sweeteners (aspartame/sucralose) in solution form.
  4. Active Ingredient: Slowly add API under continuous stirring to ensure uniform dispersion or dissolution.
  5. Buffering Agents: Add buffers such as citric acid or sodium citrate after the API is fully dissolved.
  6. Colorants and Flavors: Add permitted color solutions and flavors in the final phase after cooling (if applicable).
  7. Volume Adjustment: Adjust final volume using purified water after verifying homogeneity and pH.
See also  Elixir Department: SOP for Dispensing Excipients for Oral Liquid Formulations - V 2.0

5.3 Precautions During Addition

  1. Maintain constant stirring during and after each addition to ensure even distribution.
  2. Record the time of each addition in the BMR.
  3. Allow sufficient time between additions for complete dissolution or dispersion of each ingredient.
  4. For heat-sensitive or volatile ingredients (e.g., ethanol or flavors), add after cooling the batch to room temperature.

5.4 Documentation

  1. Enter the addition time, material name, batch number, and quantity in the Ingredient Addition Log (Annexure-1).
  2. Get verification signatures from the supervisor and QA (if required).

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • SOP: Standard Operating Procedure
  • API: Active Pharmaceutical Ingredient
  • QA: Quality Assurance

7. Documents

  1. Ingredient Addition Log (Annexure-1)
  2. Batch Manufacturing Record (BMR)
  3. Sequence Verification Checklist (Annexure-2)
See also  Elixir Department: SOP for Dispensing Humidity Sensitive Materials - V 2.0

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 970 Annex 2 – GMP Guidelines for Liquid Dosage Forms

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Ingredient Addition Log

Date Material Name Batch No. Quantity Added Time Added By Verified By
11/04/2025 Sodium Benzoate SB2025 0.500 kg 10:15 AM Rajesh Kumar Sunita Reddy

Annexure-2: Sequence Verification Checklist

Step Ingredient Order Correct (Yes/No) Verified By
1 Purified Water Yes Sunita Reddy
2 Sodium Benzoate Yes Sunita Reddy
3 Sorbitol Solution Yes Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Issue New SOP QA Head
11/04/2025 2.0 Included Verification Checklist Process Control Enhancement QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: API Manufacturing: SOP for Trending of IPC Results and Deviations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version